HOME >> BIOLOGY >> NEWS
Early infection and rejection detection

TROY, N.Y. Julie Stenken, associate professor of analytical chemistry at Rensselaer Polytechnic Institute in Troy, N.Y., has received a four-year, $750,000 grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to develop a new technique that can be used to study the body's reaction to medical implants at the cellular level. Millions of medical devices, including catheters, pacemakers, vascular grafts, and glucose sensors, are regularly implanted into humans. Despite the frequency of these procedures, implantation still poses a risk of serious side effects, including implant site infection and rejection of the implanted device. The microdialysis technique can provide information that may someday allow doctors to spot infection earlier and prevent rejection from occurring.

Tiny Samples Provide New Understanding
A microdialysis probe (the size of a 0.5 mm pencil lead) is used to withdraw a tiny sample of extracellular fluid at the site where the implant and the body's tissues meet. Analysis of the sample can detect the presence and amount of a variety of chemical markers called cytokines that may indicate early signs of responses to an implant such as infection or rejection. "If you can understand the chemical communication that is going on at the implantation site, you can ultimately bioengineer the site to make it do what is appropriate for the device," says Stenken. "The tools to measure these chemical reactions are just starting to become available to us." Stenken is collaborating with Albany Medical Center co-investigators Daniel Loegering and Michelle Lennartz.

The NIBIB coordinates with the biomedical imaging and bioengineering programs of other agencies and the National Institutes of Health to support imaging and engineering research with potential medical applications.

Stenken's microdialysis project is part of Rensselaer's focal effort to advance biotechnology discoveries for the benefit
'"/>

Contact: Joely Johnson
johnsj2@rpi.edu
518-276-6098
Rensselaer Polytechnic Institute
24-Jul-2003


Page: 1 2

Related biology news :

1. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
2. Early detection hope for eye disease
3. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
4. Early dexamethasone exposure has long-term neurodevelopment, neuroendocrine effects
5. Early predictor of breast cancer aggressiveness
6. Early treatment confirmed as key to stroke recovery
7. Early identification of kidney disease cost-effective only when directed at high-risk patients
8. Early promise for treatment of Ebola
9. Early treatment can prevent severe vision loss in premature infants
10. Early hominids may have behaved more human than we had thought
11. Early-life environments shape development of stress behaviors and learning abilities in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... ... July 01, 2020 , ... Catalent, a global ... of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture of ... located in Kakegawa, the new 60,000-square-foot facility will provide customers with flexible clinical ...
(Date:6/28/2020)... BASEL, Switzerland (PRWEB) , ... ... ... leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that ... oncology company developing innovative, full-length multispecific antibodies (Multiclonics®), to support their translational ...
(Date:6/25/2020)... (PRWEB) , ... June 24, 2020 , ... ... cloud-based enterprise software and software-driven clinical data services that accelerate drug development, is ... low-dose selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... ... engineering firm, is making available for free its new white paper – ... transport simulation testing into today’s biologics licensing application (BLA). In response, Modality ...
(Date:8/7/2020)... (PRWEB) , ... August 06, 2020 , ... ... DNA vaccine industries, announces it has closed on the purchase of greenfield for ... in Conroe, TX and includes over 21 acres in the initial acquisition, with ...
(Date:8/3/2020)... ... 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands company ... Known as MediVet Biologics since its formation in 2016, the company is relaunching ... Health will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... launch of its new tagline, “BUILDING FOR LIFE.” The adoption of this taglines ... the globe, requiring fast track capacity to provide patients with urgently needed vaccines ...
Breaking Biology Technology:
Cached News: